PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 6, 2026
$45,26
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$42,62minimo 52 sett.
$71,07massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$2.55B
P/E (TTM)
12.7
EPS (TTM)
$3.57
Ricavi (TTM)
$1.10B
i tuoi badge
Intervallo 52 sett.
$43–$71
Rating Analisti
BUY
Prezzo Obiettivo
$68
P/E
12.7
ROE
9.1%
Margine di Profitto Netto
15.6%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
PBH Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$45.26
Capitalizzazione di Mercato (MRQ)
$2.55B
P/E (TTM)
12.7
EPS (TTM)
$3.57
Ricavi (TTM)
$1.10B
ROE (TTM)
9.1%
D/E Debito/Patrimonio (MRQ)
1.1
Intervallo 52 sett.
$43–$71
PBH Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su Prestige Consumer Healthcare Inc. Common Stock Panoramica della società da Wikipedia
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
settoreHealthcare
industriaPharmaceuticals
dipendenti890
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$1.09B2017-03-31 → 2026-03-31
EPS$3.912017-03-31 → 2026-03-31
Flusso di cassa libero$246M2017-03-31 → 2026-03-31
Margine netto15.6%2017-03-31 → 2026-03-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | PBH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 12.7media 5 anni ≈5.5 | ≈5.5 | · | · | |
| P/S (TTM) | 2.3media 5 anni ≈3.3 | ≈3.3 | · | · | |
| P/B (MRQ) | 1.3media 5 anni ≈2.2 | ≈2.2 | · | · | |
| Prezzo / FCF (TTM) | 10.8media 5 anni ≈15.4 | ≈15.4 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 10.2media 5 anni ≈14.9 | ≈14.9 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | -1.9 | · | · | · | |
| PEG Ratio | ≈3.4 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | PBH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine lordo (TTM) | 53.5%media 5 anni ≈55.7% | ≈55.7% | · | · | |
| Margine Operativo (TTM) | 26.3%media 5 anni ≈23.4% | ≈23.4% | · | · | |
| Margine EBITDA (TTM) | 29.2%media 5 anni ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin (Margine ante imposte) | 23.6%media 5 anni ≈17.8% | ≈17.8% | · | · | |
| Margine di Profitto Netto (TTM) | 15.6%media 5 anni ≈13.3% | ≈13.3% | · | · | |
| ROA (TTM) | 4.3%media 5 anni ≈4.3% | ≈4.3% | · | · | |
| ROE (TTM) | 9.1%media 5 anni ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%media 5 anni ≈8.6% | ≈8.6% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | PBH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 1.1media 5 anni ≈0.8 | ≈0.8 | · | · | |
| Rapporto corrente (MRQ) | 3.2media 5 anni ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio | 2.1media 5 anni ≈1.9 | ≈1.9 | · | · | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 1.0media 5 anni ≈0.8 | ≈0.8 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | PBH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -4.3%media 5 anni ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -1.2%media 5 anni ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 2.9% | · | · | · | |
| EPS YoY | -8.9%media 5 anni ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY (Utile Netto YoY) | -11.3%media 5 anni ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | 2.0% | · | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | 3.8% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | 1.5% | · | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | 2.9% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | PBH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.3media 5 anni ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Rotazione delle scorte) | 3.2media 5 anni ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Rotazione dei crediti) | 5.6media 5 anni ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.2M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.02%
Prossimo report
Nov 04, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | $0.98 | $0.89 | 10.0% | |
| 31 Marzo 2026 | $1.23 | $1.40 | -12.4% | |
| 31 Dicembre 2025 | $1.14 | $1.16 | -1.4% | |
| 30 Settembre 2025 | $1.07 | $0.98 | 9.2% | |
| 30 Giugno 2025 | $0.95 | $1.01 | -6.0% | |
| 31 Marzo 2025 | $1.32 | $1.31 | 0.64% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
Stato Patrimoniale
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
Flusso di cassa
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
Per Azione
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
Tassi di Crescita
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Conto Economico
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
Stato Patrimoniale
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
Flusso di cassa
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
Redditività
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
Efficienza
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
Per Azione
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
Valutazione (TTM)
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ricavi | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Margine Lordo % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| Margine Operativo % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Utile netto | $190M | $215M | $209M | $-82M | $205M |
| EPS Diluito | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Metrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | · | 0.7 | 0.9 | 0.9 |
| Rapporto corrente | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| Metrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $246M | $243M | $239M | $222M | $250M |
Proprietari istituzionali (13F) 340 filer · $2.9B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
340
Valore detenuto
$2.9B
Nuove posizioni
39
Posizioni chiuse
69
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 39 (-19 vs trimestre precedente) | 69 (+29 vs trimestre precedente) | 108 (-17 vs trimestre precedente) | 119 (-10 vs trimestre precedente) | +2.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $370.187.111 | 7.831.333 | 12,99% | Azioni |
| VANGUARD GROUP INC | $332.432.481 | 5.388.758 | 11,66% | Azioni |
| ARIEL INVESTMENTS, LLC | $230.143.970 | 4.868.711 | 8,07% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133.553.822 | 2.825.340 | 4,69% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $125.802.061 | 2.661.291 | 4,41% | Azioni |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110.225.175 | 2.331.821 | 3,87% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $101.013.343 | 2.136.944 | 3,54% | Azioni |
| STATE STREET CORP | $100.047.570 | 2.116.513 | 3,51% | Azioni |
| BRANDES INVESTMENT PARTNERS, LP | $96.953.606 | 2.051.060 | 3,40% | Azioni |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88.490.528 | 1.872.023 | 3,10% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $74.306.032 | 1.571.742 | 2,61% | Azioni |
| Allspring Global Investments Holdings, LLC | $61.257.112 | 1.271.950 | 2,15% | Azioni |
| MORGAN STANLEY | $58.800.671 | 1.243.931 | 2,06% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $39.252.108 | 828.628 | 1,38% | Azioni |
| NORTHERN TRUST CORP | $36.560.934 | 773.449 | 1,28% | Azioni |
| WESTWOOD HOLDINGS GROUP INC | $35.473.535 | 750.445 | 1,24% | Azioni |
| RICE HALL JAMES & ASSOCIATES, LLC | $32.601.741 | 689.692 | 1,14% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31.134.811 | 658.659 | 1,09% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.922.805 | 654.174 | 1,08% | Azioni |
| UBS Group AG | $30.186.858 | 638.605 | 1,06% | Azioni |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29.772.348 | 629.836 | 1,04% | Azioni |
| Boston Trust Walden Corp | $28.832.289 | 609.949 | 1,01% | Azioni |
| GOLDMAN SACHS GROUP INC | $27.725.541 | 586.536 | 0,97% | Azioni |
| CITADEL ADVISORS LLC | $26.667.701 | 564.157 | 0,94% | Azioni |
| BANK OF AMERICA CORP /DE/ | $26.277.109 | 555.894 | 0,92% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $21.949.967 | 464.353 | 0,77% | Azioni |
| Leeward Investments, LLC - MA | $20.700.289 | 437.916 | 0,73% | Azioni |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19.921.578 | 421.440 | 0,70% | Azioni |
| Invesco Ltd. | $19.209.111 | 406.370 | 0,67% | Azioni |
| Woodline Partners LP | $17.004.012 | 359.721 | 0,60% | Azioni |
| ARMISTICE CAPITAL, LLC | $15.882.720 | 336.000 | 0,56% | Azioni |
| Glenmede Investment Management, LP | $15.685.425 | 251.369 | 0,55% | Azioni |
| Bank of New York Mellon Corp | $15.375.752 | 325.275 | 0,54% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $14.837.438 | 313.887 | 0,52% | Azioni |
| D. E. Shaw & Co., Inc. | $14.832.286 | 313.778 | 0,52% | Azioni |
| WELLS FARGO & COMPANY/MN | $14.604.614 | 308.962 | 0,51% | Azioni |
| Nuveen, LLC | $14.012.435 | 296.434 | 0,49% | Azioni |
| Congress Wealth Management LLC / DE / | $13.030.320 | 163.185 | 0,46% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $12.700.693 | 268.684 | 0,45% | Azioni |
| Tributary Capital Management, LLC | $11.958.554 | 252.984 | 0,42% | Azioni |
| Fisher Asset Management, LLC | $11.698.136 | 247.474 | 0,41% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $11.013.816 | 232.998 | 0,39% | Azioni |
| PRUDENTIAL FINANCIAL INC | $10.251.209 | 216.865 | 0,36% | Azioni |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10.122.871 | 214.150 | 0,36% | Azioni |
| JPMORGAN CHASE & CO | $10.050.950 | 207.249 | 0,35% | Azioni |
| Aristotle Capital Boston, LLC | $10.043.458 | 212.470 | 0,35% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $9.983.703 | 211.206 | 0,35% | Azioni |
| FMR LLC | $9.951.172 | 210.518 | 0,35% | Azioni |
| GLENMEDE TRUST CO NA | $9.729.017 | 205.818 | 0,34% | Azioni |
| JENNISON ASSOCIATES LLC | $9.393.259 | 198.715 | 0,33% | Azioni |
Insider aziendali 50 insider · 29 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 07 Maggio 2026 F | 373.465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 01 Giugno 2015 M | 27.706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 03 Marzo 2009 P | 177.168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 Maggio 2006 P | 33.278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 02 Maggio 2026 F | 57.374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 09 Maggio 2016 A | 11.050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 Maggio 2010 D | 401.850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 Maggio 2026 S | 41.810 | 0 | 7 | $-246.374 |
| Adel Mekhail | EVP, Marketing & Sales | 07 Maggio 2026 F | 25.703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 04 Maggio 2026 A | 28.149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 06 Gennaio 2026 A | 3.436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 07 Maggio 2025 F | 17.051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 09 Maggio 2019 F | 21.717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 Maggio 2018 M | 11.081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 07 Maggio 2018 A | 8.150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 Agosto 2017 F | 6.678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 Maggio 2017 F | 62.075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 Maggio 2016 M | 55.927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 Maggio 2016 M | 32.176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 Maggio 2014 M | 15.282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 Maggio 2011 F | 13.236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 Maggio 2010 D | 28.331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 Maggio 2010 D | 16.640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 Marzo 2009 D | 30.579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 Marzo 2009 D | 90.846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 Maggio 2008 A | 27.427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 02 Gennaio 2007 D | 289.172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 Febbraio 2005 S | 180.560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 Febbraio 2005 S | 72.347 | 0 | 0 | $0 |
| Sheila Hopkins | Direttore | 05 Agosto 2025 A | 30.123 | 0 | 0 | $0 |
| Natale S Ricciardi | Direttore | 01 Agosto 2023 A | 27.098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Direttore | 02 Agosto 2022 A | 13.218 | 0 | 0 | $0 |
| James M Jenness | Direttore | 04 Agosto 2020 A | 22.791 | 0 | 0 | $0 |
| Carl J Johnson | Direttore | 31 Luglio 2018 A | 14.598 | 0 | 0 | $0 |
| Charles Hinkaty | Direttore | 04 Agosto 2015 A | 31.714 | 0 | 0 | $0 |
| Patrick Lonergan | Direttore | 10 Dicembre 2012 G | 37.323 | 0 | 0 | $0 |
| John Byom | Direttore | 03 Agosto 2010 A | 29.755 | 0 | 0 | $0 |
| Vincent J Hemmer | Direttore | 10 Settembre 2009 J | 80.410 | 0 | 0 | $0 |
| Peter Mann | Direttore | 04 Agosto 2009 A | 447.700 | 0 | 0 | $0 |
| Dick L Buell | Direttore | 04 Agosto 2009 A | 27.662 | 0 | 0 | $0 |
| David Donnini | Direttore | 29 Maggio 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | Direttore | 05 Agosto 2008 A | 30.352 | 0 | 0 | $0 |
| Raymond Silcock | Direttore | 05 Agosto 2008 A | 16.249 | 0 | 0 | $0 |
| John F. Kelly | · | 04 Agosto 2026 A | 7.832 | 0 | 0 | $0 |
| James Darecca | · | 04 Agosto 2026 A | 9.572 | 0 | 0 | $0 |
| Dawn M. Zier | · | 04 Agosto 2026 A | 19.514 | 0 | 0 | $0 |
| Celeste A. Clark | · | 04 Agosto 2026 A | 16.511 | 0 | 0 | $0 |
| John E Byom | · | 04 Agosto 2026 A | 54.575 | 0 | 1 | $-178.050 |
| COSTLEY GARY E | · | 04 Agosto 2020 A | 50.200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | 29 Maggio 2009 S | 0 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 67 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,86% | 347.516 SH | 01 Ottobre 2026 | Giornaliero |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,17% | 45.519 SH | 01 Ottobre 2026 | Giornaliero |
| PILL · Direxion Shares ETF Trust | 1,16% | 4.781 NS | 31 Luglio 2026 | N-PORT |
| HSMV · First Trust Exchange-Traded Fund III | 0,80% | 5.597 NS | 31 Luglio 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,65% | 25.280 NS | 31 Luglio 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,59% | 201 NS | 31 Luglio 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,52% | 3.105 NS | 31 Luglio 2026 | N-PORT |
| IHE · iShares Trust | 0,51% | 175.342 SH | 11 Settembre 2026 | Giornaliero |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,34% | 92.272 NS | 31 Luglio 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,25% | 181.211 NS | 31 Luglio 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100.520 SH | 19 Agosto 2026 | Giornaliero |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 18.534 NS | 31 Luglio 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41.965 SH | 19 Agosto 2026 | Giornaliero |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,15% | 7.601 SH | 01 Ottobre 2026 | Giornaliero |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,13% | 4.372 NS | 31 Luglio 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165.811 SH | 19 Agosto 2026 | Giornaliero |
| ROSC · Lattice Strategies Trust | 0,12% | 1.466 NS | 31 Luglio 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 195.077 NS | 31 Luglio 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 8.140 SH | 01 Ottobre 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 67.943 SH | 01 Ottobre 2026 | Giornaliero |
| EBIT · Harbor ETF Trust | 0,11% | 258 NS | 31 Luglio 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1.747 NS | 31 Luglio 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 43.685 NS | 31 Luglio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 11.789 NS | 31 Luglio 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7.246 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,08% | 22.923 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 1.227.360 SH | 11 Settembre 2026 | Giornaliero |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175.325 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275.721 SH | 19 Agosto 2026 | Giornaliero |
| DFAT · Dimensional ETF Trust | 0,07% | 196.959 NS | 31 Luglio 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28.729 SH | 01 Ottobre 2026 | Giornaliero |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690.582 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,05% | 152.317 NS | 31 Luglio 2026 | N-PORT |
| IGRO · iShares Trust | 0,05% | 10.967 SH | 11 Settembre 2026 | Giornaliero |
| WSML · iShares Trust | 0,04% | 5.420 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22.700 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 544.134 SH | 19 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1.087.231 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,03% | 142.413 SH | 19 Agosto 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,01% | 117.382 NS | 31 Luglio 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 36.640 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 5.233 NS | 31 Luglio 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 688.472 SH | 19 Agosto 2026 | Giornaliero |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 453.610 SH | 19 Agosto 2026 | Giornaliero |
| VSGX · VANGUARD WORLD FUND | 0,01% | 9.203 SH | 19 Agosto 2026 | Giornaliero |
| IDEV · iShares Trust | 0,01% | 52.014 SH | 11 Settembre 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,01% | 829 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.004 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.442 NS | 31 Luglio 2026 | N-PORT |
| IXUS · iShares Trust | 0,01% | 56.667 SH | 11 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 69.137 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 14.019 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,00% | 6.651 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10.940 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.510.012 SH | 19 Agosto 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 69.368 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.089 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,00% | 10.506 SH | 19 Agosto 2026 | Giornaliero |
| IJR · iShares Trust | · | 2.889.316 SH | 10 Settembre 2026 | Giornaliero |
| IJS · iShares Trust | · | 422.466 SH | 08 Settembre 2026 | Giornaliero |
| IWN · iShares Trust | · | 449.434 SH | 11 Settembre 2026 | Giornaliero |
| XJR · iShares Trust | · | 6.541 SH | 31 Agosto 2026 | Giornaliero |
| SVAL · iShares Trust | · | 10.792 SH | 03 Settembre 2026 | Giornaliero |
| ISCB · iShares Trust | · | 1.977 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 9.565 SH | 11 Settembre 2026 | Giornaliero |
| SMLF · iShares Trust | · | 38.488 SH | 11 Settembre 2026 | Giornaliero |
| SMMV · iShares Trust | · | 20.132 SH | 25 Agosto 2026 | Giornaliero |
PBH Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 10 analisti
COMPRA
Target mediano
$70.00
+54,7%
3 30,0%
Acquisto forte
4 40,0%
Compra
3 30,0%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
5 analisti · 2026-10-03Target medio $67.80 +49,8%
← Sotto tutti i target
Prezzo attuale $45.26
Basso$55.00
Media$67.80
Alto$75.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026